158 related articles for article (PubMed ID: 15604125)
1. Thyroid hormones induce unique and potentially beneficial changes in cardiac myocyte shape in hypertensive rats near heart failure.
Thomas TA; Kuzman JA; Anderson BE; Andersen SM; Schlenker EH; Holder MS; Gerdes AM
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2118-22. PubMed ID: 15604125
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.
Peterson JT; Hallak H; Johnson L; Li H; O'Brien PM; Sliskovic DR; Bocan TM; Coker ML; Etoh T; Spinale FG
Circulation; 2001 May; 103(18):2303-9. PubMed ID: 11342481
[TBL] [Abstract][Full Text] [Related]
3. p38 MAP kinase activity is correlated with angiotensin II type 1 receptor blocker-induced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats.
Liang Q; Elson AC; Gerdes AM
J Card Fail; 2006 Aug; 12(6):479-86. PubMed ID: 16911916
[TBL] [Abstract][Full Text] [Related]
4. Longstanding hyperthyroidism is associated with normal or enhanced intrinsic cardiomyocyte function despite decline in global cardiac function.
Weltman NY; Wang D; Redetzke RA; Gerdes AM
PLoS One; 2012; 7(10):e46655. PubMed ID: 23056390
[TBL] [Abstract][Full Text] [Related]
5. Correlation of myocyte lengthening to chamber dilation in the spontaneously hypertensive heart failure (SHHF) rat.
Tamura T; Onodera T; Said S; Gerdes AM
J Mol Cell Cardiol; 1998 Nov; 30(11):2175-81. PubMed ID: 9925355
[TBL] [Abstract][Full Text] [Related]
6. Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension.
Onodera T; Tamura T; Said S; McCune SA; Gerdes AM
Hypertension; 1998 Oct; 32(4):753-7. PubMed ID: 9774375
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenergic activation initiates chamber dilatation in concentric hypertrophy.
Badenhorst D; Veliotes D; Maseko M; Tsotetsi OJ; Brooksbank R; Naidoo A; Woodiwiss AJ; Norton GR
Hypertension; 2003 Mar; 41(3):499-504. PubMed ID: 12623950
[TBL] [Abstract][Full Text] [Related]
8. Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system.
Tamura T; Said S; Harris J; Lu W; Gerdes AM
Circulation; 2000 Jul; 102(2):253-9. PubMed ID: 10889139
[TBL] [Abstract][Full Text] [Related]
9. Effects of induced hyperthyroidism in normal and cardiomyopathic hamsters.
Kuzman JA; Thomas TA; Vogelsang KA; Said S; Anderson BE; Gerdes AM
J Appl Physiol (1985); 2005 Oct; 99(4):1428-33. PubMed ID: 15976357
[TBL] [Abstract][Full Text] [Related]
10. Rat strain-related differences in myocardial adrenergic tone and the impact on cardiac fibrosis, adrenergic responsiveness and myocardial structure and function.
Osadchii O; Norton G; Deftereos D; Woodiwiss A
Pharmacol Res; 2007 Apr; 55(4):287-94. PubMed ID: 17257851
[TBL] [Abstract][Full Text] [Related]
11. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy.
Minhas KM; Saraiva RM; Schuleri KH; Lehrke S; Zheng M; Saliaris AP; Berry CE; Barouch LA; Vandegaer KM; Li D; Hare JM
Circ Res; 2006 Feb; 98(2):271-9. PubMed ID: 16357304
[TBL] [Abstract][Full Text] [Related]
12. Cardiac myofibrillar contractile properties during the progression from hypertension to decompensated heart failure.
Hanft LM; Emter CA; McDonald KS
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H103-H113. PubMed ID: 28455288
[TBL] [Abstract][Full Text] [Related]
13. Myocyte remodeling during the progression to failure in rats with hypertension.
Gerdes AM; Onodera T; Wang X; McCune SA
Hypertension; 1996 Oct; 28(4):609-14. PubMed ID: 8843886
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.
Gómez-Garre D; González-Rubio ML; Muñoz-Pacheco P; Caro-Vadillo A; Aragoncillo P; Fernández-Cruz A
Eur J Heart Fail; 2010 Sep; 12(9):903-12. PubMed ID: 20601374
[TBL] [Abstract][Full Text] [Related]
15. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.
Anderson KM; Eckhart AD; Willette RN; Koch WJ
Hypertension; 1999 Jan; 33(1 Pt 2):402-7. PubMed ID: 9931137
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats.
Tsotetsi OJ; Woodiwiss AJ; Netjhardt M; Qubu D; Brooksbank R; Norton GR
Hypertension; 2001 Oct; 38(4):846-51. PubMed ID: 11641297
[TBL] [Abstract][Full Text] [Related]
17. Effect of low thyroid function on cardiac structure and function in spontaneously hypertensive heart failure rats.
Kisso B; Patel A; Redetzke R; Gerdes AM
J Card Fail; 2008 Mar; 14(2):167-71. PubMed ID: 18325465
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease.
Ishizu T; Seo Y; Kameda Y; Kawamura R; Kimura T; Shimojo N; Xu D; Murakoshi N; Aonuma K
Hypertension; 2014 Mar; 63(3):500-6. PubMed ID: 24396022
[TBL] [Abstract][Full Text] [Related]
19. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
20. Gender-specific effects of thyroid hormones on cardiopulmonary function in SHHF rats.
Schlenker EH; Tamura T; Gerdes AM
J Appl Physiol (1985); 2003 Dec; 95(6):2292-8. PubMed ID: 12909610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
